Operating Margin of Cytek Biosciences, Inc. from 31 Dec 2020 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cytek Biosciences, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2020 to 30 Sep 2024.
  • Cytek Biosciences, Inc. Operating Margin for the quarter ending 30 Sep 2024 was -12%, a 91% increase year-over-year.
  • Cytek Biosciences, Inc. annual Operating Margin for 2023 was -14%, a 76% increase from 2022.
  • Cytek Biosciences, Inc. annual Operating Margin for 2022 was -61%, a 115% decline from 2021.
  • Cytek Biosciences, Inc. annual Operating Margin for 2021 was 420%, a 78% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Cytek Biosciences, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -12% +114% +91% 01 Jul 2024 30 Sep 2024
Q2 2024 -13% +124% +90% 01 Apr 2024 30 Jun 2024
Q1 2024 -13% +220% +94% 01 Jan 2024 31 Mar 2024
Q4 2023 -14% +46% +76% 01 Oct 2023 31 Dec 2023
Q3 2023 -125% -123% -6226% 01 Jul 2023 30 Sep 2023
Q2 2023 -137% -141% -3315% 01 Apr 2023 30 Jun 2023
Q1 2023 -233% -276% -633% 01 Jan 2023 31 Mar 2023
Q4 2022 -61% -481% -115% 01 Oct 2022 31 Dec 2022
Q3 2022 -2% 01 Jul 2022 30 Sep 2022
Q2 2022 4.2% 01 Apr 2022 30 Jun 2022
Q1 2022 44% 01 Jan 2022 31 Mar 2022
Q4 2021 420% 01 Oct 2021 31 Dec 2021

Cytek Biosciences, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -14% +46% +76% 01 Jan 2023 31 Dec 2023
2022 -61% -481% -115% 01 Jan 2022 31 Dec 2022
2021 420% -1504% -78% 01 Jan 2021 31 Dec 2021
2020 1924% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.